Old Web
English
Sign In
Acemap
>
authorDetail
>
Taylor Keaton
Taylor Keaton
Medical College of Wisconsin
Medicine
Ixazomib
Refractory Multiple Myeloma
Bendamustine
Internal medicine
3
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Metabolically Reprogrammed Polyclonal Autologous Rapa-201 Cell Therapy Yields a Promising Safety and Efficacy Profile in Relapsed and Refractory Multiple Myeloma (RRMM)
2021
Blood
Binod Dhakal
Tânia C Felizardo
Lawrence G. Lum
Anita DSouza
Saurabh Chhabra
Taylor Keaton
Meera Mohan
Jee H Park
Daniel H. Fowler
Parameswaran Hari
Show All
Source
Cite
Save
Citations (0)
Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
2019
Blood Cancer Journal
Binod Dhakal
Anita D'Souza
Mehdi Hamadani
Carlos Arce-Lara
Katrina Schroeder
Saurabh Chhabra
Nirav N. Shah
Katelyn Gauger
Taylor Keaton
Marcelo C. Pasquini
Parameswaran Hari
Show All
Source
Cite
Save
Citations (8)
Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM)
2018
Blood
Binod Dhakal
Anita D'Souza
Mehdi Hamadani
Carlos Arce-Lara
Katrina Schroeder
Saurabh Chhabra
Nirav N. Shah
Katelyn Gauger
Taylor Keaton
Marcelo C. Pasquini
Parameswaran Hari
Show All
Source
Cite
Save
Citations (0)
1